FROBEN tablets or suppositories

País: África do Sul

Língua: inglês

Origem: South African Health Products Regulatory Authority (SAHPRA)

Ingredientes ativos:

flurbiprofen

Disponível em:

Knoll

DCI (Denominação Comum Internacional):

flurbiprofen

Dosagem:

50 mg or 100 mg

Forma farmacêutica:

tablets or suppositories

Área terapêutica:

Antirheumatic (anti-inflammatory agent)

Folheto informativo - Bula

INDICATIONS [/za_1123.html#1]
  [/za_1123.html#1]     [/za_1123.html#1]
CONTRA-INDICATIONS [/za_1123.html#1]
      [/za_1123.html#1]
DOSAGE [/za_1123.html#1]
      [/za_1123.html#1]
SIDE-EFFECTS [/za_1123.html#1]
  [/za_1123.html#1]     [/za_1123.html#1]
PREGNANCY [/za_1123.html#1]
      [/za_1123.html#1]
OVERDOSE [/za_1123.html#1]

IDENTIFICATION [/za_1123.html#1]
  [/za_1123.html#1]    PATIENT INFORMATION
FROBEN 50 : TABLETS
FROBEN 100 : TABLETS
FROBEN : SUPPOSITORIES
SCHEDULING STATUS
Schedule 3
PROPRIETARY NAME 
(and dosage form)
FROBEN 50 : TABLETS
FROBEN 100 : TABLETS
FROBEN : SUPPOSITORIES
COMPOSITION
Tablets
50 mg : Each sugar coated tablet contains 50 mg 
FLURBIPROFEN

100 mg : Each sugar coated tablet contains 100 mg flurbiprofen
Suppositories

: Each suppository contains 100 mg flurbiprofen
PHARMACOLOGICAL CLASSIFICATION
A3.1/Antirheumatic (anti-inflammatory agent).
PHARMACOLOGICAL ACTION
FROBEN, chemically described as 2-(2-fluoro-4-biphenylyl) propionic acid, is a non-steroidal anti-inflammatory agent
which has significant anti-inflammatory, analgesic and antipyretic properties. FROBEN is an inhibitor of prostaglandin
synthetase enzymes which are known to be associated with inflammation, pain and fever.
INDICATIONS
FROBEN is indicated in the treatment of rheumatoid arthritis, osteo-arthritis and ankylosing spondylitis. FROBEN is
also indicated for the relief of pain following soft tissue trauma, dental surgery, dysmenorrhoea, post episiotomy pain
and post partum pain.
CONTRA-INDICATIONS
FROBEN should not be given to patients with peptic ulceration. The safety of FROBEN during pregnancy or lactation
has not been established. FROBEN should be prescribed with caution for those patients with asthma, and especially
for patients who have developed bronchospasm with other non-steroidal agents. Should no